Drug intelligence / Profile preview

oat beta-glucan + beta-glucanase

Development stage
Unknown
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes, Microbiome Therapeutics
Administration
Oral
01

Overview

Oat beta-glucan + beta-glucanase is a combination of a soluble dietary fiber (oat beta-glucan, derived from the endosperm of oat kernels) and the enzyme beta-glucanase, which hydrolyzes beta-glucan[2][3]. Oat beta-glucan is well-established for its cholesterol-lowering and prebiotic properties, and has regulatory recognition for cardiovascular risk reduction[2]. Beta-glucanase enzymatic treatment breaks down β-glucan polymers into shorter oligomers, improving their fermentability by gut microbiota, enhancing both prebiotic and immunomodulatory effects, especially notable in infant gut models and dendritic cell activation[3]. The combination is primarily investigated as a functional food ingredient or supplement, especially for improving digestive health, immune function, and metabolic parameters via both fiber action and enzymatic modification[1][3]. Mechanistically, oat beta-glucan acts by increasing gut viscosity, interfering with nutrient absorption and binding bile acids, thereby reducing cholesterol absorption[1][2]. Beta-glucanase increases the solubility and fermentability of beta-glucan, leading to greater production of short-chain fatty acids and enhanced immune signaling through Dectin-1 activation[3].

Other names
oat beta-glucan and beta-glucanase
02

Targets

CLEC7A (Dectin-1)β-glucan (Beta-glucan)

Beyond the preview

Go deeper on oat beta-glucan + beta-glucanase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oat beta-glucan + beta-glucanase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call